Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
454.95B
Market cap454.95B
Price-Earnings ratio
18.01
Price-Earnings ratio18.01
Dividend yield
2.72%
Dividend yield2.72%
Average volume
8.10M
Average volume8.10M
High today
$189.30
High today$189.30
Low today
$186.57
Low today$186.57
Open price
$187.56
Open price$187.56
Volume
2.44M
Volume2.44M
52 Week high
$194.48
52 Week high$194.48
52 Week low
$140.68
52 Week low$140.68

JNJ News

Simply Wall St 2h
Protagonist Therapeutics: Assessing Valuation After Breakthrough Phase 2b Results and Johnson & Johnson’s Phase 3 Launch

Protagonist Therapeutics (PTGX) drew investor attention after reporting strong Phase 2b results for its drug icotrokinra. This development led Johnson & Johnson...

Protagonist Therapeutics: Assessing Valuation After Breakthrough Phase 2b Results and Johnson & Johnson’s Phase 3 Launch
Nasdaq 3h
Guru Fundamental Report for JNJ

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Inves...

Guru Fundamental Report for JNJ
TipRanks 1d
Trump Trade: Texas sues Kenvue, J&J over Tylenol autism risk

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump...

Analyst ratings

56%

of 27 ratings
Buy
55.6%
Hold
37%
Sell
7.4%

More JNJ News

Nasdaq 1d
JNJ Factor-Based Stock Analysis

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...

JNJ Factor-Based Stock Analysis
TipRanks 1d
Johnson & Johnson to begin FcRn blockers study

Johnson & Johnson announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis, or gMG, whic...

Benzinga 2d
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson (NYSE:JNJ) and Kenvue Inc (NYSE:KVUE), accusing the companies of misleading preg...

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
TipRanks 2d
Citi says headlines could push consumers to alternatives to Kenvue’s Tylenol

After Texas Attorney General Ken Paxton announced he has sued Johnson & Johnson (JNJ) and Kenvue (KVUE) for marketing Tylenol to pregnant mothers, Citi analyst...

TipRanks 2d
Texas AG’s Tylenol Lawsuit Rattles Kenvue Stock

Kenvue (KVUE) stock fell on Tuesday after Texas Attorney General Ken Paxton filed a lawsuit against the company over allegations that Tylenol is tied to autism....

Simply Wall St 2d
Is Johnson & Johnson’s Recent 5.9% Rise Backed by Its Intrinsic Value in 2025?

Deciding what to do with Johnson & Johnson stock these days is a lot like weighing your options at a crossroads. From long-time holders to investors peering in...

Is Johnson & Johnson’s Recent 5.9% Rise Backed by Its Intrinsic Value in 2025?
Nasdaq 2d
Dow Movers: JNJ, SHW

In early trading on Tuesday, shares of Sherwin-Williams topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Y...

Dow Movers: JNJ, SHW

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.